Go to main content

Press Releases

Explore the archived press releases about AOP Health, its products, studies and cooperations. We will be happy to answer any questions or comments you may have via aop-health@aoporphan.com 

AOP Orphan Statement on SARS-CoV-2 and COVID-19

17. 3. 2020

AOP Orphan will distribute Wakix® (pitolisant) from Bioprojet Pharma SAS in Austria, Nordic countries and Central Eastern Europe

22. 3. 2018

The Medical University of Innsbruck: Christian Doppler Laboratory for Iron Metabolism and Anemia Research is opened.

5. 2. 2018

AOP Orphan Pharmaceuticals AG to acquire Selisistat a clinical stage drug candidate for the treatment of Huntington’s disease (HD)

2. 10. 2017

AOP Orphan strengthens core CNS specialty business with high promise in movement disorder treatments

19. 6. 2015

Homozygous Familial Hypercholesterolaemia

30. 4. 2015